Results 131 to 140 of about 689,446 (396)

Are Financial Incentives for Patients an Effective Treatment for Hypertension Attention-Deficit Disorder? [PDF]

Hypertension, 2022
Shapiro MF.
europepmc   +1 more source

Advances in Microfluidic Cochlea‐On‐A‐Chip

Advanced Science, EarlyView.
This review systematically examines diverse cell sources for inner ear organoids and outlines stepwise induction protocols. Furthermore, it discusses current applications and prospective developments of cochlea‐on‐a‐chip technologies in areas such as deafness modeling, mechanistic studies, and drug evaluation, with particular focus on gene‐therapy drug
Tian Shen, Shanying Han, Weiwei He, Wen Yang, Xinghua Tang, Xiaolong Zhao, Xinghong Liu, Zhenhua Shao, Lin Cheng, Yu Zhao, Jiangang Fan   +10 more
wiley   +1 more source

MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder

Neural Regeneration Research
Inappropriate levels of hyperactivity, impulsivity, and inattention characterize attention deficit hyperactivity disorder, a common childhood-onset neuropsychiatric disorder.
Bridget Martinez, Philip V Peplow
doaj   +1 more source

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder. [PDF]

Front Psychiatry, 2022
Nunez NA, Coombes BJ, Romo-Nava F, Bond DJ, Vande Voort J, Croarkin PE, Leibman N, Gardea Resendez M, Veldic M, Betcher H, Singh B, Colby C, Cuellar-Barboza A, Prieto M, Moore KM, Ozerdem A, McElroy SL, Frye MA, Biernacka JM.   +18 more
europepmc   +1 more source

FURTHER EXAMINATION OF DIAGNOSTIC CRITERIA FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER (DSM-IV) IN A COUNTY-WIDE SAMPLE. †110 [PDF]

, 1996
Mark L. Wolraich, Jane N. Hannah, Anna Baumgaertel, Theodora Y. Pinnock   +3 more
openalex   +1 more source

NAD+‐Boosters Improve Mitochondria Quality Control In Parkinson's Disease Models Via Mitochondrial UPR

Advanced Science, EarlyView.
Treatment of MPTP‐incubated cells with NAD+‐boosters increase the UPRmt/mitophagy‐related mitochondria quality control (MQC). Disturbed plasma UPRmt‐mitophagy‐mediated MQC profiles in PD patient samples. NMN inhibits motor deficit and forestalls neuropathology phenotypes of PD mice, which is required the atf4‐medicated UPRmt pathway.
Shuoting Zhou, Xi Xiong, Jialong Hou, Qi Duan, Yi Zheng, Tao Jiang, Jiani Huang, Haijun He, Jiaxue Xu, Keke Chen, Wenwen Wang, Jinlai Cai, Jingjing Qian, Huijun Chen, Weihong Song, XinShi Wang, Chenglong Xie   +16 more
wiley   +1 more source

Attention-deficit Disorder, Family Factors, and Oral Health Literacy. [PDF]

Int Dent J, 2022
de Moura MFL, Firmino RT, Neves ÉTB, Costa EMMB, Paiva SM, Ferreira FM, Granville-Garcia AF.   +6 more
europepmc   +1 more source

GROWTH HORMONE THERAPY IN CHILDREN WITH ATTENTION DEFICIT DISORDERS TREATED WITH METHYLPHENIDATE OR PEMOLINE: NATIONAL COLLABORATIVE GROWTH STUDY(NCGS) EXPERIENCE. 561 [PDF]

, 1996
Jay Rao, Joanne R. Julius, Kevin Connelly   +2 more
openalex   +1 more source

Attention Deficit HyperactivityDisorder (ADHD): Survey Report [PDF]

, 2017
In the spring of 2016, the New Hampshire Pediatric Improvement Partnership (NHPIP) conducted an online survey of NH pediatric and family practice clinicians to understand practice patterns, comfort level, and support needs relative to caring for ...
Daviss, W. Burl, House, Samantha, Olson, Ardis, O’Neil, Molly, Porter, Josephine, Ryer, Jeanne, EdD, Tutko, Holly Deblois   +6 more
core   +1 more source

Consequences and Mechanisms of Noise‐Induced Cochlear Synaptopathy and Hidden Hearing Loss, With Focuses on Signal Perception in Noise and Temporal Processing

Advanced Science, EarlyView.
Noise‐induced synaptopathy (NIS) is largely reversible due to self‐repair. NIS and noise‐induced hidden hearing loss are two concepts with similarities and differences. The major hearing deficits in NIHHL are temporal processing disorders. The translation of animal data in NIS studies to humans is hindered by many factors.
Hui Wang, Steven J Aiken, Jian Wang
wiley   +1 more source